Clinical Trials

Overview

About this study

The purpose of this study is to pilot the use of a remote electroencephalography (EEG) tool in neonates who are at increased risk for seizure. This will be used to assess the need for initiation of formal EEG, as well as, the need to escalate care in at risk neonates. This will be trialed in neonates who are demonstrating signs at birth of mild neonatal encephalopathy, as determined clinically by the neonatologist.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information